home / stock / bvs / bvs news


BVS News and Press, Bioventus Inc. From 08/08/23

Stock Information

Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Website: bioventus.com

Menu

BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...

BVS - Bioventus GAAP EPS of -$0.06 beats by $0.10, revenue of $137.1M beats by $7.87M

2023-08-08 07:37:58 ET Bioventus press release ( NASDAQ: BVS ): Q2 GAAP EPS of -$0.06 beats by $0.10 . Revenue of $137.1M (-2.3% Y/Y) beats by $7.87M . For further details see: Bioventus GAAP EPS of -$0.06 beats by $0.10, revenue of $137.1M beats by $7.87M

BVS - Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the three and six months ended July 1, 2023. Q2 Financial Summary: Net Sales ...

BVS - Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference

DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, will present at the Canaccord Genuity Global Growth Conference on Thursday, ...

BVS - Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2023 before ...

BVS - Top Insider Picks June 2023

2023-07-13 08:30:00 ET Summary June 2023 saw significant insider purchases in Lucid Group, Diversified Healthcare Trust, Akoya Biosciences, and Axon Enterprise. The Public Investment Fund bought $1.8 billion worth of shares in Lucid Group, increasing its ownership to 74.95%. Diver...

BVS - Bioventus: Return Of The King

2023-06-28 14:18:00 ET Summary Shares of medical device concern Bioventus Inc. have more than tripled off their May 4th intraday low as a decent Q1 2023 report and the return of its ex-CEO have provided confidence. That said, Bioventus stock is still off over 80% from its all-time...

BVS - Aldeyra, Bioventus top healthcare gainers; Mersana, Bone Biologics among losers

2023-06-15 10:06:53 ET Gainers: Aldeyra Therapeutics ( ALDX ) +11% . Bioventus ( BVS ) +11% . IO Biotech ( IOBT ) +11% . Verastem ( VSTM ) +10% . Zentalis Pharmaceuticals ( ZNTL ) +9% . Losers: Mersana Therapeutics ( MRSN...

BVS - Best Penny Stocks Today? 3 Under $1 To Watch Now

2023-05-24 10:16:32 ET If you’re looking for the best penny stocks to buy today , you should be well-prepared to deal with high volatility. Whether it’s the latest debt ceiling crisis, pandemic fear reemerging, today’s Fed meeting minutes from May, or speeches by Ja...

BVS - Bioventus Completes Divestiture of its Wound Business

DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully completed the divestiture of its Wound business, including the s...

BVS - ICPT, MNK and TRMD are among pre market losers

2023-05-22 08:53:42 ET Rain Oncology ( RAIN ) +-82% Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma. Volcon ( VLCN ) +-30% slides after announcing new equity offering. Mallinckrodt ( MNK...

Previous 10 Next 10